STEMI, ultrasound to treat heart attacks, ultrasound to treat STEMI

Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 

At the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 6-10 at the Baltimore Convention Center, Siemens Healthcare debuted new technologies designed to expand the capabilities and improve the productivity of molecular imaging. Symbia Evo, Siemens’ new single-photon emission computed tomography (SPECT) system, boosts user productivity, providing facilities with more time to plan treatment schedules, personalize studies, serve additional patients and improve workflow efficiency.

Patients who received a bare metal coronary stent did not display significant differences in rates of adverse events with an additional 18 months of dual antiplatelet therapy rather than placebo, according to a study in the March 17 issue of JAMA. The study looked at rates of stent thrombosis, major adverse cardiac and cerebrovascular events, and moderate or severe bleeding. The authors note that limitations in sample size may make definitive conclusions regarding these findings difficult.

C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the pass-through payment for the Lutonix drug-coated balloon (DCB) under the Medicare hospital outpatient prospective payment system. The purpose of the reimbursement is to cover additional cost to U.S. hospitals for treating Medicare beneficiaries with the Lutonix DCB in the outpatient setting.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now